Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. BA

Go back to Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 2c

August 8, 2023 4:04 PM EDT

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of ($0.68), $0.02 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $960 thousand versus the consensus estimate of $4.36 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

... More